Rewisca Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each hard capsule contains 25, mg, 75 mg or 150 mg pregabalin.
Excipients/Inactive Ingredients: Capsule contents: Pregelatinised starch, Talc (E553b).
Capsule shell: 25 mg hard capsules: titanium dioxide (E171), gelatin, black printing ink (shellac, black iron oxide (E172), propylene glycol) in capsule shell.
75 mg hard capsules: titanium dioxide (E171), gelatin, yellow iron oxide (E172), black printing ink (shellac, black iron oxide (E172), propylene glycol) in capsule shell.
150 mg hard capsules: titanium dioxide (E171), gelatin, red iron oxide (E172), yellow iron oxide (E172), black printing ink (shellac, black iron oxide (E172), propylene glycol) in capsule shell.

pregabalin

Manufacturer:

KRKA

Distributor:

Uni Drug